Liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus infection

Lulu ZHOU, Bing DONG, Jiejing XIN, Guanghua XU, Na LIU

PDF(729 KB)
PDF(729 KB)
Journal of Clinical Hepatol ›› 2025, Vol. 41 ›› Issue (1) : 52-56. DOI: 10.12449/JCH250108
Viral Hepatitis

Liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus infection

Author information +
History +

Abstract

Objective To investigate the liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus (HBV) infection. Methods A total of 271 patients with low-viral-load HBeAg-negative chronic HBV infection who underwent liver biopsy in Department of Infectious Diseases, Affiliated Hospital of Yan’an University, from September 2013 to June 2021 were enrolled as subjects, and the degree of liver injury was compared between patients based on age, sex, presence or absence of the family history of hepatitis B, HBsAg, and alanine aminotransferase (ALT) level. The chi-square test was used for comparison of categorical data between two groups. Results Among the 271 patients with HBeAg-negative chronic HBV infection, 86 patients (31.73%) grade≥A2 liver inflammatory activity, 72 (26.57%) had a liver fibrosis stage of ive, and 112 (41.33%) had moderate or severe liver histological injury. The proportion of patients with grade≥A2 liver inflammatory activity in the patients with ALT>20 U/L was significantly higher than that in the patients with ALT≤20 U/L (χ2=3.938, P=0.047). There were no significant differences in the proportion of patients with grade≥A2 liver inflammatory activity between the patients with different ages, sexes, family history of hepatitis B, HBsAg levels (all P>0.05),there were no significant differences in the proportion of patients with a liver fibrosis stage of ≥F2 between the patients with different ages, sexes, family history of hepatitis B, HBsAg, and ALT levels (all P>0.05), and the stratified analysis of patients aged≤30 years and patients without the family history of hepatitis B showed no statistical significance between groups (all P>0.05). There was no significant difference in the degree of liver histological injury between the patients with different ages, sexes, family history of hepatitis B, HBsAg, and ALT levels (all P>0.05). Conclusion Significant liver injury is observed in more than 40% of the patients with low-viral-load HBeAg-negative chronic HBV infection, and there is no significant difference in the degree of liver histological injury between the patients with different ages, sexes, family history of hepatitis B, HBsAg, and ALT levels. Even for the patients aged≤30 years who deny the family history of hepatitis B, there is still a considerable proportion of patients with liver injury, which should be taken seriously by clinicians.

Key words

Hepatitis B, Chronic / Viral Load / Inflammation / Hepatic Fibrosis / Liver Injury

Cite this article

Download Citations
Lulu ZHOU , Bing DONG , Jiejing XIN , et al . Liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus infection. Journal of Clinical Hepatol. 2025, 41(1): 52-56 https://doi.org/10.12449/JCH250108

References

1
Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(2022 version)[J]. Chin J Infect Dis, 2023, 4(1): 3-28. DOI: 10.3760/cma.j.cn11365-20230220-00050 .
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版)[J]. 中华传染病杂志, 2023, 41(1): 3-28. DOI: 10.3760/cma.j.cn311365-20230220-00050 .
2
YAO K, LIU J, WANG J, et al. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone[J]. J Viral Hepat, 2021, 28(7): 1025-1033. DOI: 10.1111/jvh.13511 .
3
ZHAN J, WANG J, ZHANG Z, et al. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase[J]. Virulence, 2023, 14(1): 2268497. DOI: 10.1080/21505594.2023.2268497 .
4
HUANG DQ, LI X, LE MH, et al. Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1803-1812. e5. DOI: 10.1016/j.cgh.2021.01.019 .
5
HUANG DQ, TRAN A, YEH ML, et al. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase[J]. Hepatology, 2023, 78(5): 1558-1568. DOI: 10.1097/HEP.0000000000000459 .
6
MARTIN P, NGUYEN MH, DIETERICH DT, et al. Treatment algorithm for managing chronic hepatitis B virus infection in the United States: 2021 update[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1766-1775. DOI: 10.1016/j.cgh.2021.07.036 .
7
KAO JH, HU TH, JIA J, et al. East Asia expert opinion on treatment initiation for chronic hepatitis B[J]. Aliment Pharmacol Ther, 2020, 52(10): 1540-1550. DOI: 10.1111/apt.16097 .
8
WEI S, XIE Q, LIAO G, et al. Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged<30 years may exhibit significant histologic damage[J]. BMC Gastroenterol, 2024, 24(1): 120. DOI: 10.1186/s12876-024-03208-9 .
9
RUGGIERI A, GAGLIARDI MC, ANTICOLI S. Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses?[J]. Front Immunol, 2018, 9: 2302. DOI: 10.3389/fimmu.2018.02302 .
10
NING HB, JIN HM, LI K, et al. Liver pathological characteristics and the value of serum non-invasive diagnostic model in chronic hepatitis B patients with normal alanine aminotransferase and negative hepatitis B antigen[J]. Chin J Infect Dis, 2022, 40(12): 729-734. DOI: 103760/cma.j.cn311365-20220321-0009 .
宁会彬, 靳慧鸣, 李宽, 等. 丙氨酸转氨酶正常的乙型肝炎e抗原阴性慢性乙型肝炎患者的肝脏病理特征及血清学无创诊断模型价值分析[J]. 中华传染病杂志, 2022, 40(12): 729-734. DOI: 10.3760/cma.j.cn311365-20220321-0009 .
11
SONNEVELD MJ, BROUWER WP, HANSEN BE, et al. Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis[J]. Aliment Pharmacol Ther, 2020, 52(8): 1399-1406. DOI: 10.1111/apt.16067 .
12
GAO Y, WANG M, LIU X. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase[J]. Microbiol Spectr, 2024, 12(4): e0394123. DOI: 10.1128/spectrum.03941-23 .
13
Chinese Society of Hepatology, Chinese Medical Association. Expert opinion on expanding anti-HBV treatment for chronic hepatitis B[J].Chin J Hepatol, 2022, 30(2): 131-136. DOI: 10.3760/cma.j.cn501113-20220209-00060 .
中华医学会肝病学分会. 扩大慢性乙型肝炎抗病毒治疗的专家意见[J]. 中华肝脏病杂志, 2022, 30(2): 131-136. DOI: 10.3760/cma.j.cn501113-20220209-00060 .
14
DUAN M, CHI X, XIAO H, et al. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B[J]. Hepatol Int, 2021, 15(2): 318-327. DOI: 10.1007/s12072-021-10153-2 .

周路路负责撰写论文;东冰、辛杰晶负责数据收集和分析;徐光华、刘娜负责研究设计,拟定写作思路,指导撰写文章并最后定稿。

Funding

Yan’an City Science and Technology Research and Development Plan(2014HM-09)

Comments

PDF(729 KB)

Accesses

Citation

Detail

Sections
Recommended

/